Alignment Healthcare (ALHC) president sells shares under 10b5-1 plan

Q: What insider transaction did ALHC disclose in this Form 4?

The Form 4 reports that Dawn Christine Maroney , President of Alignment Healthcare, Inc. (ALHC) , sold shares of the company’s common stock in two transactions on 01/15/2026 .

Q: How many Alignment Healthcare (ALHC) shares did Dawn Maroney sell?

On 01/15/2026 , Dawn Maroney sold 15,129 shares of Alignment Healthcare common stock in one transaction and 14,871 shares in a second transaction.

Q: At what prices were the ALHC shares sold in this Form 4?

The first sale was at a weighted-average price of $22.1875 per share, based on trades between $21.58 and $22.57 . The second sale was at a weighted-average price of $22.781 per share, based on trades between $22.58 and $22.98 .

Q: Were the ALHC insider sales made under a Rule 10b5-1 trading plan?

Yes. The filing notes a Rule 10b5-1 plan adoption date of 05/22/2025 , indicating the sales were executed pursuant to that pre-established trading plan.

Q: What does “weighted-average price” mean in this ALHC Form 4?

The filing explains that each reported price is a weighted-average price , because the shares were sold in multiple individual trades within the stated price ranges. Full trade‑by‑trade details are available upon request from the company, its security holders, or the SEC staff.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Alignment Healthcare president Dawn Christine Maroney reported insider sales of company stock. On 01/15/2026, she sold 15,129 shares of common stock at a weighted-average price of $22.1875 per share and an additional 14,871 shares at a weighted-average price of $22.781 per share.

The filing states these transactions were made under a Rule 10b5-1 trading plan adopted on 05/22/2025. The prices reflect multiple trades, with per‑share prices ranging from $21.58 to $22.57 for the first group and $22.58 to $22.98 for the second. After these sales, Maroney directly owned 1,027,015 shares of Alignment Healthcare common stock.

Insider Trade Summary

Net Seller: 30,000 shares ($674,451)

Net Sell 2 txns

Insider Maroney Dawn Christine

Role President

Sold 30,000 shs ($674K)

Type	Security	Shares	Price	Value
Sale	Common Stock	15,129	$22.1875	$336K
Sale	Common Stock	14,871	$22.781	$339K

Holdings After Transaction: Common Stock — 1,041,886 shares (Direct)

Footnotes (1)

Date of Rule 10b5-1 plan adoption: 05/22/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.58 to $22.57. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $22.58 to $22.98. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Form 4 Insider Transactions: What Each Field Means →

01/16/2026 - 05:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last)

(First)

(Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE

92868

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/15/2026		S⁽¹⁾		15,129	D	$22.1875⁽²⁾	1,041,886	D
Common Stock	01/15/2026		S⁽¹⁾		14,871	D	$22.781⁽³⁾	1,027,015	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 05/22/2025

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.58 to $22.57. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $22.58 to $22.98. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ALHC disclose in this Form 4?

The Form 4 reports that Dawn Christine Maroney, President of Alignment Healthcare, Inc. (ALHC), sold shares of the company’s common stock in two transactions on 01/15/2026.

How many Alignment Healthcare (ALHC) shares did Dawn Maroney sell?

On 01/15/2026, Dawn Maroney sold 15,129 shares of Alignment Healthcare common stock in one transaction and 14,871 shares in a second transaction.

At what prices were the ALHC shares sold in this Form 4?

The first sale was at a weighted-average price of $22.1875 per share, based on trades between $21.58 and $22.57. The second sale was at a weighted-average price of $22.781 per share, based on trades between $22.58 and $22.98.

Does Dawn Maroney still own Alignment Healthcare (ALHC) stock after these sales?

Yes. After the reported transactions, Dawn Maroney directly owned 1,027,015 shares of Alignment Healthcare common stock.

Were the ALHC insider sales made under a Rule 10b5-1 trading plan?

Yes. The filing notes a Rule 10b5-1 plan adoption date of 05/22/2025, indicating the sales were executed pursuant to that pre-established trading plan.

What does “weighted-average price” mean in this ALHC Form 4?

The filing explains that each reported price is a weighted-average price, because the shares were sold in multiple individual trades within the stated price ranges. Full trade‑by‑trade details are available upon request from the company, its security holders, or the SEC staff.